Haemonetics Corporation (HAE)
USD 78.77
(-4.02%)
USD 78.77
(-4.02%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 676.53 Million USD | 12.43% |
| 2023 | 615.09 Million USD | 21.68% |
| 2022 | 505.5 Million USD | 27.06% |
| 2021 | 397.83 Million USD | -17.89% |
| 2020 | 484.51 Million USD | 16.04% |
| 2019 | 417.53 Million USD | 1.37% |
| 2018 | 411.9 Million USD | 8.83% |
| 2017 | 378.49 Million USD | -6.75% |
| 2016 | 405.87 Million USD | -6.57% |
| 2015 | 434.41 Million USD | -7.25% |
| 2014 | 468.36 Million USD | 9.4% |
| 2013 | 428.13 Million USD | 15.95% |
| 2012 | 369.24 Million USD | 3.95% |
| 2011 | 355.2 Million USD | 5.25% |
| 2010 | 337.48 Million USD | 9.51% |
| 2009 | 308.17 Million USD | 19.57% |
| 2008 | 257.72 Million USD | 13.39% |
| 2007 | 227.3 Million USD | 3.07% |
| 2006 | 220.53 Million USD | 11.45% |
| 2005 | 197.87 Million USD | 14.96% |
| 2004 | 172.12 Million USD | 11.26% |
| 2003 | 154.69 Million USD | -0.09% |
| 2002 | 154.83 Million USD | -7.24% |
| 2001 | 166.91 Million USD | 6.84% |
| 2000 | 156.22 Million USD | -1.19% |
| 1999 | 158.1 Million USD | -0.38% |
| 1998 | 158.7 Million USD | -7.73% |
| 1997 | 172 Million USD | 2.56% |
| 1996 | 167.7 Million USD | 5.8% |
| 1995 | 158.5 Million USD | 2.79% |
| 1994 | 154.2 Million USD | 20.94% |
| 1993 | 127.5 Million USD | 30.23% |
| 1992 | 97.9 Million USD | -37.76% |
| 1991 | 157.3 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 170.51 Million USD | 1.94% |
| 2024 Q4 | 171.59 Million USD | -3.52% |
| 2024 Q3 | 177.86 Million USD | 4.31% |
| 2024 FY | 676.53 Million USD | 9.99% |
| 2024 Q1 | 167.26 Million USD | 7.05% |
| 2023 Q1 | 142.26 Million USD | 4.37% |
| 2023 Q2 | 157.87 Million USD | 10.98% |
| 2023 Q3 | 158.7 Million USD | 0.53% |
| 2023 Q4 | 156.24 Million USD | -1.55% |
| 2023 FY | 615.09 Million USD | 21.68% |
| 2022 Q4 | 136.31 Million USD | -1.63% |
| 2022 FY | 505.5 Million USD | 27.06% |
| 2022 Q2 | 122.54 Million USD | 13.37% |
| 2022 Q3 | 138.56 Million USD | 13.08% |
| 2022 Q1 | 108.08 Million USD | 32.12% |
| 2021 Q3 | 120.25 Million USD | 13.72% |
| 2021 Q1 | 90.03 Million USD | -20.72% |
| 2021 Q2 | 105.74 Million USD | 17.45% |
| 2021 FY | 397.83 Million USD | -17.89% |
| 2021 Q4 | 81.8 Million USD | -31.97% |
| 2020 Q3 | 128.05 Million USD | 0.83% |
| 2020 Q2 | 127 Million USD | 9.57% |
| 2020 Q4 | 113.55 Million USD | -11.32% |
| 2020 FY | 484.51 Million USD | 16.04% |
| 2020 Q1 | 115.9 Million USD | 4.22% |
| 2019 Q2 | 111.9 Million USD | 34.43% |
| 2019 Q4 | 111.21 Million USD | 0.03% |
| 2019 Q3 | 111.17 Million USD | -0.65% |
| 2019 Q1 | 83.24 Million USD | -20.25% |
| 2019 FY | 417.53 Million USD | 1.37% |
| 2018 Q2 | 104.56 Million USD | 14.07% |
| 2018 FY | 411.9 Million USD | 8.83% |
| 2018 Q4 | 104.38 Million USD | -6.21% |
| 2018 Q1 | 91.66 Million USD | 11.64% |
| 2018 Q3 | 111.29 Million USD | 6.44% |
| 2017 Q1 | 91.05 Million USD | 2.1% |
| 2017 FY | 378.49 Million USD | -6.75% |
| 2017 Q2 | 104.24 Million USD | 14.49% |
| 2017 Q4 | 82.11 Million USD | -18.77% |
| 2017 Q3 | 101.07 Million USD | -3.04% |
| 2016 Q3 | 108.85 Million USD | 3.38% |
| 2016 FY | 405.87 Million USD | -6.57% |
| 2016 Q1 | 102.53 Million USD | -5.38% |
| 2016 Q4 | 89.18 Million USD | -18.07% |
| 2016 Q2 | 105.29 Million USD | 2.69% |
| 2015 Q1 | 106.27 Million USD | -7.94% |
| 2015 Q4 | 108.36 Million USD | -2.95% |
| 2015 Q3 | 111.66 Million USD | 3.28% |
| 2015 FY | 434.41 Million USD | -7.25% |
| 2015 Q2 | 108.11 Million USD | 1.73% |
| 2014 Q1 | 111.41 Million USD | -9.52% |
| 2014 FY | 468.36 Million USD | 9.4% |
| 2014 Q3 | 121.62 Million USD | 1.46% |
| 2014 Q2 | 119.88 Million USD | 7.6% |
| 2014 Q4 | 115.44 Million USD | -5.09% |
| 2013 Q3 | 113.11 Million USD | 11.16% |
| 2013 Q2 | 101.76 Million USD | 12.93% |
| 2013 Q1 | 90.11 Million USD | -4.75% |
| 2013 FY | 428.13 Million USD | 15.95% |
| 2013 Q4 | 123.14 Million USD | 8.86% |
| 2012 Q2 | 89.94 Million USD | 1.35% |
| 2012 Q3 | 95.93 Million USD | 6.65% |
| 2012 Q4 | 94.61 Million USD | -1.38% |
| 2012 Q1 | 88.74 Million USD | 1.43% |
| 2012 FY | 369.24 Million USD | 3.95% |
| 2011 Q3 | 93.49 Million USD | 6.54% |
| 2011 Q1 | 86.46 Million USD | -1.88% |
| 2011 Q2 | 87.75 Million USD | 1.49% |
| 2011 FY | 355.2 Million USD | 5.25% |
| 2011 Q4 | 87.5 Million USD | -6.41% |
| 2010 Q2 | 80.96 Million USD | -2.38% |
| 2010 Q1 | 82.94 Million USD | 0.97% |
| 2010 FY | 337.48 Million USD | 9.51% |
| 2010 Q4 | 88.12 Million USD | 3.13% |
| 2010 Q3 | 85.44 Million USD | 5.53% |
| 2009 Q3 | 78.29 Million USD | 4.83% |
| 2009 Q2 | 74.68 Million USD | 2.26% |
| 2009 Q4 | 82.14 Million USD | 4.92% |
| 2009 Q1 | 73.03 Million USD | 4.66% |
| 2009 FY | 308.17 Million USD | 19.57% |
| 2008 FY | 257.72 Million USD | 13.39% |
| 2008 Q4 | 69.78 Million USD | 4.85% |
| 2008 Q3 | 66.55 Million USD | 11.14% |
| 2008 Q1 | 61.49 Million USD | 5.39% |
| 2008 Q2 | 59.88 Million USD | -2.61% |
| 2007 Q1 | 57.37 Million USD | -2.06% |
| 2007 FY | 227.3 Million USD | 3.07% |
| 2007 Q4 | 58.34 Million USD | 3.42% |
| 2007 Q3 | 56.41 Million USD | 2.28% |
| 2007 Q2 | 55.16 Million USD | -3.86% |
| 2006 Q2 | 51.76 Million USD | -5.06% |
| 2006 Q1 | 54.52 Million USD | 2.02% |
| 2006 FY | 220.53 Million USD | 11.45% |
| 2006 Q4 | 58.57 Million USD | 5.22% |
| 2006 Q3 | 55.66 Million USD | 7.54% |
| 2005 Q2 | 45.54 Million USD | -3.29% |
| 2005 FY | 197.87 Million USD | 14.96% |
| 2005 Q1 | 47.1 Million USD | -1.96% |
| 2005 Q3 | 51.78 Million USD | 13.68% |
| 2005 Q4 | 53.44 Million USD | 3.22% |
| 2004 FY | 172.12 Million USD | 11.26% |
| 2004 Q2 | 41.38 Million USD | 4.53% |
| 2004 Q4 | 48.04 Million USD | 11.43% |
| 2004 Q1 | 39.58 Million USD | 9.3% |
| 2004 Q3 | 43.11 Million USD | 4.19% |
| 2003 Q4 | 36.21 Million USD | -11.54% |
| 2003 FY | 154.69 Million USD | -0.09% |
| 2003 Q3 | 40.94 Million USD | 5.27% |
| 2003 Q2 | 38.89 Million USD | 0.63% |
| 2003 Q1 | 38.64 Million USD | 3.09% |
| 2002 FY | 154.83 Million USD | -7.24% |
| 2002 Q2 | 39.8 Million USD | 9.64% |
| 2002 Q1 | 36.3 Million USD | -15.79% |
| 2002 Q3 | 41.23 Million USD | 3.6% |
| 2002 Q4 | 37.48 Million USD | -9.09% |
| 2001 FY | 166.91 Million USD | 6.84% |
| 2001 Q1 | 39.44 Million USD | 6.54% |
| 2001 Q2 | 39.32 Million USD | -0.29% |
| 2001 Q3 | 45.03 Million USD | 14.5% |
| 2001 Q4 | 43.1 Million USD | -4.27% |
| 2000 Q3 | 38.6 Million USD | -4.46% |
| 2000 FY | 156.22 Million USD | -1.19% |
| 2000 Q4 | 37.02 Million USD | -4.08% |
| 2000 Q1 | 40.2 Million USD | 6.35% |
| 2000 Q2 | 40.4 Million USD | 0.5% |
| 1999 Q1 | 42.8 Million USD | -8.74% |
| 1999 FY | 158.1 Million USD | -0.38% |
| 1999 Q4 | 37.8 Million USD | -1.56% |
| 1999 Q3 | 38.4 Million USD | -2.29% |
| 1999 Q2 | 39.3 Million USD | -8.18% |
| 1998 Q4 | 46.9 Million USD | 60.62% |
| 1998 FY | 158.7 Million USD | -7.73% |
| 1998 Q1 | 42.4 Million USD | 2.66% |
| 1998 Q2 | 40.2 Million USD | -5.19% |
| 1998 Q3 | 29.2 Million USD | -27.36% |
| 1997 Q1 | 44.8 Million USD | 11.72% |
| 1997 Q4 | 41.3 Million USD | -2.13% |
| 1997 Q3 | 42.2 Million USD | -3.21% |
| 1997 Q2 | 43.6 Million USD | -2.68% |
| 1997 FY | 172 Million USD | 2.56% |
| 1996 Q2 | 42.7 Million USD | 2.89% |
| 1996 Q1 | 41.5 Million USD | 5.87% |
| 1996 Q3 | 43.4 Million USD | 1.64% |
| 1996 FY | 167.7 Million USD | 5.8% |
| 1996 Q4 | 40.1 Million USD | -7.6% |
| 1995 Q4 | 39.2 Million USD | -1.26% |
| 1995 Q1 | 39.4 Million USD | 1.03% |
| 1995 Q2 | 40.3 Million USD | 2.28% |
| 1995 Q3 | 39.7 Million USD | -1.49% |
| 1995 FY | 158.5 Million USD | 2.79% |
| 1994 Q2 | 39.7 Million USD | 10.89% |
| 1994 Q1 | 35.8 Million USD | 4.99% |
| 1994 FY | 154.2 Million USD | 20.94% |
| 1994 Q4 | 39 Million USD | -1.76% |
| 1994 Q3 | 39.7 Million USD | 0.0% |
| 1993 Q3 | 33.8 Million USD | 8.33% |
| 1993 Q4 | 34.1 Million USD | 0.89% |
| 1993 FY | 127.5 Million USD | 30.23% |
| 1993 Q1 | 28.5 Million USD | 4.4% |
| 1993 Q2 | 31.2 Million USD | 9.47% |
| 1992 Q3 | 25.7 Million USD | 9.83% |
| 1992 Q4 | 27.3 Million USD | 6.23% |
| 1992 Q2 | 23.4 Million USD | 9.35% |
| 1992 FY | 97.9 Million USD | -37.76% |
| 1992 Q1 | 21.4 Million USD | -45.69% |
| 1991 Q2 | 39.3 Million USD | 0.0% |
| 1991 Q1 | 39.3 Million USD | 0.0% |
| 1991 Q3 | 39.3 Million USD | 0.0% |
| 1991 Q4 | 39.4 Million USD | 0.25% |
| 1991 FY | 157.3 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alcon Inc. | 5.6 Billion USD | 87.936% |
| AptarGroup, Inc. | 1.26 Billion USD | 46.451% |
| Baxter International Inc. | 4.97 Billion USD | 86.401% |
| Becton, Dickinson and Company | 9.15 Billion USD | 92.609% |
| Bausch + Lomb Corporation | 2.5 Billion USD | 72.982% |
| Envista Holdings Corp | 1.45 Billion USD | 53.358% |
| ResMed Inc. | 2.6 Billion USD | 74.067% |
| Teleflex Incorporated | 1.64 Billion USD | 58.921% |
| Warby Parker Inc. | 365.22 Million USD | -85.239% |
| West Pharmaceutical Services, Inc. | 1.12 Billion USD | 40.087% |